2 completed, 1 terminated. 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow BG 9928: new trials by email Literature Review of BG 9928 trials Research Report on BG 9928
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BG9928 in Subjects With Hepatic Impairment BG9928 - Hepatic Impairment | Phase 1 | Completed | Biogen | 23 | 2009-04-01 | 2010-01-27 |
| Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency Tonapofylline, Placebo - Renal Insufficiency, Heart Failure | Phase 2 | Terminated | Biogen | 34 | 2009-02-01 | 2023-09-11 |
| Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency tonapofylline, Placebo - Renal Insufficiency, Congestive Heart Failure | Phase 3 | Completed | Biogen | 420 | 2008-07-31 | 2023-09-11 |
Heart Failure (2) · Renal Insufficiency (2)
Biogen (3)
United States (3) · Argentina (1) · Australia (1) · Brazil (1) · Bulgaria (1) · Canada (1) · Czechia (1) · Finland (1) · France (1) · Germany (1) · India (1) · Israel (1) · Italy (1) · Netherlands (1) · Poland (1)